Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:51 AM
Ignite Modification Date:
2025-12-26 @ 1:33 AM
NCT ID:
NCT01730833
Group ID:
EG001
Title:
Cohort 2: HER2+ Locally Advanced Breast Cancer (LABC) Patients
Description:
Pertuzumab administered as 840 mg IV during cycle 1 followed by 420 mg IV once every three weeks starting cycle 2.
Trastuzumab loading dose of 4mg/kg IV for week one followed by 2mg/kg IV weekly.
Nab-paclitaxel 100 mg/m2 IV weekly.
Treatment is scheduled to continue until:
A planned 6 cycles Unmanageable toxicity Primary physician or patient request to discontinue therapy Study termination by the sponsors
Deaths Number Affected:
2
Deaths Number At Risk:
None
Serious Number Affected:
4
Serious Number At Risk:
45
Other Number Affected:
45
Other Number At Risk:
45
Study:
NCT01730833
Results Section:
NCT01730833
Adverse Events Module:
NCT01730833